SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
Holding GB:SBTX?
Track your performance easily

SkinBioTherapeutics (SBTX) Balance Sheet

8 Followers

SkinBioTherapeutics Balance Sheet

SkinBioTherapeutics's total assets for Q2 2023 were £1.99M, a decrease of -35.55% from the previous quarter. GB:SBTX total liabilities were £775.80K for the fiscal quarter, a 27.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Assets
£ 2.59M£ 3.08M£ 5.73M£ 2.77M£ 3.93M
Total Liabilities
£ 599.34K£ 609.61K£ 519.67K£ 304.82K£ 121.33K
Total Equity Gross Minority
£ 1.99M£ 2.48M£ 5.22M£ 2.47M£ 3.81M
Total Capitalization
£ 1.99M£ 2.48M£ 5.22M£ 2.47M£ 3.81M
Preferred Stock Equity
-----
Capital Lease Obligations
---£ 0.00-
Currency in GBP

SkinBioTherapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis